Description
Retatrutide – Triple Agonist Research Peptide
Product Overview
Retatrutide is a next-generation synthetic peptide designed to act as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is currently under extensive investigation for its role in metabolic regulation, energy expenditure, and appetite signaling.
Its multi-pathway mechanism distinguishes it from traditional single-pathway peptides, making it a key compound in advanced metabolic and obesity research models.
Product Specifications
- Peptide Name: Retatrutide
- Class: GLP-1 / GIP / Glucagon receptor agonist
- Purity: ≥99% (HPLC tested)
- Form: Lyophilized powder
- Available Sizes: 5mg / 10mg / 30mg
- Appearance: White crystalline powder
- Storage: Store in a cool, dry environment
Mechanism of Action (Research Context)
- Activates GLP-1 receptors → appetite regulation
- Activates GIP receptors → insulin signaling pathways
- Activates glucagon receptors → energy expenditure
- Promotes multi-pathway metabolic activity
Research Applications
- Metabolic regulation studies
- Obesity and weight loss models
- Appetite and satiety signaling research
- Energy expenditure and fat oxidation studies
Analytical Validation
- Verified via HPLC testing
- Third-party tested for purity and consistency
- Batch-level quality control
Disclaimer
This product is intended strictly for laboratory research use only.
Not for human or animal consumption.
Must be handled by qualified professionals only.
Reviews
There are no reviews yet.